CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway

Molecular and Cellular Biochemistry

Volumn 372, Issue 1-2, 2013, Pages 1-8

  Zhong, Jialing ^a   Zhao, Mei ^a   Luo, Qing ^a   Ma, Yiming ^a   Liu, Jian ^a   Wang, Jia ^a   Yang, Mei ^a   Yuan, Xinghua ^a   Sang, Jianli ^b   Huang, Changzhi ^a  

^a CANCER HOSPITAL   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

CCDC134; Gastric cancer; MAPK pathway; MMP 2; MMP 9; RNAi

Indexed keywords

COILED COIL DOMAIN CONTAINING 134 PROTEIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SECRETORY PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; RNA INTERFERENCE; STATISTICAL ANALYSIS; STOMACH CANCER; TISSUE MICROARRAY; TRANSIENT TRANSFECTION;

CELL LINE; CELL MOVEMENT; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84870401718     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1418-4     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
2. Cunningham D, Chua YJ (2007) East meets west in the treatment of gastric cancer. N Engl J Med 357:1863-1865
3. De Vita F, Vecchione L, Galizia G, Di Martino N, Fabozzi T, Catalano G, Ciardiello F, Orditura M (2009) Perspectives in adjuvant therapy of gastric cancer. Oncology 77(Suppl 1):38-42
4. Reddy KB, Nabha SM, Atanaskova N (2003) Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22:395-403
5. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537-549
6. Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ (2005) Increased expression of mitogen-activated protein kinase and its upstream regulation signal in human gastric cancer. World J Gastroenterol 11(5):623-628
7. Huang J, Shi T, Ma T, Zhang Y, Ma X, Lu Y, Song Q, Liu W, Ma D, Qiu X (2008) CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK. Cell Mol Life Sci 65:338-349
8. Guo X, Ma N, Wang J, Song J, Bu X, Cheng Y, Sun K, Xiong H, Jiang G, Zhang B, Wu M, Wei L (2008) Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC cancer 8:375
9. Whyte J, Bergin O, Bianchi A, McNally S, Martin F (2009) Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res 11(5):209-222
10. Schubbert S, Shannon K, Bollag G (2007) Hyperactive ras in developmental disorders and cancer. Nat Rev Cancer 7(4):295-308
11. Zhang C, Zhu H, Yang X, Lou J, Zhu D, Lu W, He Q, Yang B (2010) P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549. J Cancer Res Clin Oncol 136(3):437-445
12. Uzgare AR, Kaplan PJ, Greenberg NM (2003) Differential expression and/or activation of p38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate 55(2):128-139
13. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA (2007) Role of the Raf/MEK/ERK pathway in cell growth, malignant, transformation and drug resistance. Biochim Biophys Acta 1773(8):1263-1284
14. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291-3310
15. Wang L, Gao X, Gao P, Deng W, Yu P, Ma J, Guo J, Wang X, Cheng H, Zhang C, Yu C, Ma X, Lv B, Lu Y, Shi T, Ma D (2006) Cell-based screening and validation of human novel genes associated with cell viability. J Biomol Screen 11(4):369-376
16. Tian L, Wang P, Guo J, Wang X, Deng W, Zhang C, Fu D, Gao X, Shi T, Ma D (2007) Screening for novel human genes associated with CRE path-way activation with cell microarray. Genomics 90(1):28-34
17. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K (2003) JNK phosphorylates paxillin and regulates cell migration. Nature 424:219-223
18. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619-4628
19. Egeblad M, Werb Z (2002) New function for matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174
20. Gialel C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278(1):16-27
21. Overall CM, López-Otín C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2(9):657-672
22. Behren A, Simon C, Schwab RM, Loetzsch E, Brodbeck S, Huber E, Stubenrauch F, Zenner HP, Iftner T (2005) Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Cancer Res 65(24):11613-11621
23. Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, Foschi M, Kähäri VM, Leppä S (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212(2):489-497
24. Tang FY, Chiang EP, Sun YC (2008) Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer Cells. J Nutr Biochem 19(5):287-294
25. Cheng YC, Chen LM, Chang MH, Chen WK, Tsai FJ, Tsai CH, Lai TY, Kuo WW, Huang CY, Liu CJ (2009) Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells. Mol Cell Biochem 325(1-2):15-23